LAVA Therapeutics NV Working Capital to Net Assets Ratio
LAVA Therapeutics NV working capital to net assets ratio. LAVA Therapeutics NV (LVTX) has a Working Capital to Net Assets ratio of 375.9% as of September 2025. Working capital of $47.67 Million (current assets of $51.91 Million minus current liabilities of $4.23 Million) is measured against net assets of $12.68 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check LVTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of LAVA Therapeutics NV (2019–2024)
Working capital to net assets ratio of LAVA Therapeutics NV from 2019 to 2024. This chart shows how LAVA Therapeutics NV's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 375.9%, reflecting working capital of $47.67 Million against net assets of $12.68 Million USD. See LVTX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
LAVA Therapeutics NV Working Capital to Net Assets Ratio by Year (2019–2024)
LAVA Therapeutics NV working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for LAVA Therapeutics NV from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LVTX total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 220.9% | $61.29 Million | $27.75 Million | $79.30 Million | $18.01 Million | ▲ +56.9 pp |
| 2023 | 164.0% | $83.96 Million | $51.18 Million | $98.90 Million | $14.94 Million | ▲ +26.2 pp |
| 2022 | 137.8% | $118.58 Million | $86.04 Million | $140.53 Million | $21.95 Million | ▲ +32.0 pp |
| 2021 | 105.8% | $125.26 Million | $118.37 Million | $136.50 Million | $11.25 Million | ▼ -37.0 pp |
| 2020 | 142.9% | $10.89 Million | $7.62 Million | $18.22 Million | $7.33 Million | ▲ +36.8 pp |
| 2019 | 106.0% | $6.20 Million | $5.84 Million | $7.62 Million | $1.42 Million | — |